Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Annals of Hematology
Published in: Annals of Hematology 3/2008

01-03-2008 | Letter to the Editor

Acute lymphoblastic leukemia subsequent to autoimmune hemolytic anemia: a case report

Authors: Pasquale Niscola, Laura Scaramucci, Alessio Perrotti, Stefano Fratoni, Daniela Piccioni, Andrea Tendas, Luca Cupelli, Teresa Dentamaro, Giovanni Del Poeta, Paolo de Fabritiis

Published in: Annals of Hematology | Issue 3/2008

Login to get access

Excerpt

Dear Editor, …
Literature
1.
Smedby KE, Hjalgrim H, Askling J, Chang ET, Gregersen H, Porwit-MacDonald A, Sundstrom C, Akerman M, Melbye M, Glimelius B, Adami HO (2006) Autoimmune and chronic inflammatory disorders and risk of non-Hodgkin lymphoma by subtype. J Natl Cancer Inst 98(1):51–60, Jan 4PubMedCrossRef
2.
Ehrenfeld M, Abu-Shakra M, Buskila D, Shoenfeld Y (2001) The dual association between lymphoma and autoimmunity. Blood Cells Mol Dis 27(4):750–756, Jul–AugPubMedCrossRef
3.
Sohngen D, Heyll A, Meckenstock G, Arning M, Runde V, Schneider W, Wernet P (1992) Cold agglutinin autoimmune hemolytic anemia as a severe complication in B-cell acute lymphocytic leukemia. Transfusion 32(8):790–791, OctPubMedCrossRef
4.
Teachey DT, Felix CA (2005) Development of cold agglutinin autoimmune hemolytic anemia during treatment for pediatric acute lymphoblastic leukemia. J Pediatr Hematol Oncol 27(7):397–399, JulPubMedCrossRef
5.
Stern M, Buser AS, Lohri A, Tichelli A, Nissen-Druey C (2007) Autoimmunity and malignancy in hematology-More than an association. Crit Rev Oncol Hematol 63(2):100–110, AugPubMedCrossRef
Metadata
Title
Acute lymphoblastic leukemia subsequent to autoimmune hemolytic anemia: a case report
Authors
Pasquale Niscola
Laura Scaramucci
Alessio Perrotti
Stefano Fratoni
Daniela Piccioni
Andrea Tendas
Luca Cupelli
Teresa Dentamaro
Giovanni Del Poeta
Paolo de Fabritiis
Publication date
01-03-2008
Publisher
Springer-Verlag
Published in
Annals of Hematology / Issue 3/2008
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-007-0370-y

Other articles of this Issue 3/2008

Annals of Hematology 3/2008 Go to the issue

Letter to the editor

Primary plasma cell leukemia with initial cutaneous involvement and IgA biclonal gammopathy

Original Article

Cholesterol levels in patients with multiple myeloma

Original Article

Overexpression of BP1, a homeobox gene, is associated with resistance to all-trans retinoic acid in acute promyelocytic leukemia cells

Letter to the Editor

Absent immunoglobulins in HIV-related Burkitt lymphoma/leukaemia

Letter to the Editor

Ciprofloxacin inhibits lipopolysaccharide-induced toll-like receptor-4 and 8 expression on human monocytes derived from adult and cord blood

Letter to the Editor

Autologous peripheral blood stem cell transplantation in a patient with POEMS syndrome
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits